Sorafenib-induced Thyroiditis in FMS-like Tyrosine Kinase 3-internal Tandem Duplication-mutated Acute Myeloid Leukemia

被引：0
|
作者：
Jie Sun [1 ]
Juan Hu [1 ]
Yan Huang [1 ]
Shuang-Wei Ying [1 ]
Xiao-Yan Han [1 ]
Yan-Long Zheng [1 ]
He Huang [1 ]
机构：
[1] Bone Marrow Transplantation Centre,The First Affiliated Hospital of Zhejiang University
来源：
中华医学杂志英文版 | 2016年 / 129卷 / 20期
基金：
中国国家自然科学基金;
关键词：
D O I：
暂无
中图分类号：
R581.4 [甲状腺炎]; R733.7 [白血病];
学科分类号：
1002 ; 100201 ; 100214 ;
摘要：
To the Editor:Sorafenib is a novel,orally available inhibitor of multiple kinases.It has been used in relapsed and refractory FMS-like tyrosine kinase（FLT） -3-positive acute myeloid leukemia（AML） in recent years with favorable outcomes.Thyroiditis and hypothyroidism as side effects have been reported in treatment on renal cell cancer.;Here,we report a case of FLT3-internal tandem duplication（ITD） -positive AML,who developed subacute thyroiditis during treatment with sorafenib.
引用
收藏
页码：2512 / 2513
页数：2
相关论文
共 50 条
  • [41] Maintenance sorafenib is superior to prophylactic donor lymphocyte infusion at improving the prognosis of acute myeloid leukemia with FMS-like tyrosine kinase 3 internal tandem duplication after allogeneic hematopoietic stem cell transplantation
    Jimin Shi
    Liqin Cao
    Yi Luo
    Yanmin Zhao
    Yamin Tan
    Jian Yu
    Xiaoyu Lai
    Yuanyuan Zhu
    Yongxian Hu
    Jingsong He
    Jie Sun
    Weiyan Zheng
    Guoqing Wei
    He Huang
    Bone Marrow Transplantation, 2021, 56 : 293 - 296
  • [42] Efficacy and Feasibility of Sorafenib As a Maintenance Agent after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Mutated Acute Myeloid Leukemia
    Battipaglia, Giorgia
    Ruggeri, Annalisa
    Jestin, Matthieu
    Massoud, Radwan
    El Cheikh, Jean
    Antar, Ahmad
    Ahmed, Syed Osman
    Rasheed, Walid
    Belhocine, Ramdane
    Brissot, Eolia
    Dulery, Remy
    Eder, Sandra
    Giannotti, Federica
    Isnard, Francoise
    Lapusan, Simona
    Rubio, Marie-Therese
    Vekhoff, Anne
    Aljurf, Mahmoud
    Legrand, Ollivier
    Mohty, Mohamad
    Bazarbachi, Ali
    BLOOD, 2016, 128 (22)
  • [43] The Outcome of Allogeneic Hematopoietic Cell Transplantation for Children with FMS-Like Tyrosine Kinase 3 Internal Tandem Duplication-Positive Acute Myelogenous Leukemia
    Schechter, Tal
    Gassas, Adam
    Chen, Heidi
    Pollard, Jessica
    Meshinchi, Soheil
    Zaidman, Irina
    Hitzler, Johann
    Abdelhaleem, Mohamed
    Ho, Richard
    Domm, Jennifer
    Woolfrey, Ann
    Frangoul, Haydar
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (01) : 172 - 175
  • [44] Molecular Involvement and Prognostic Importance of Fms-like Tyrosine Kinase 3 in Acute Myeloid Leukemia
    Shahab, Sadaf
    Shamsi, Tahir S.
    Ahmed, Nuzhat
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (09) : 4215 - 4220
  • [45] Internal tandem duplication and Asp835 mutation of the FMS-like tyrosine kinase 3 (FLT3) gene in children with acute promyelocytic leukemia
    Hoshi, Y
    Rikiishi, T
    Fujii, K
    Suwabe, N
    Imaizumi, M
    Iinuma, K
    Tsurusawa, M
    Horibe, K
    Hara, J
    Tsukimoto, I
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 73 - 73
  • [46] Internal tandem duplication of fms-like tyrosine kinase 3 is associated with poor outcome in patients with myelodysplastic syndrome
    Shih, LY
    Lin, TL
    Wang, PN
    Wu, JH
    Dunn, P
    Kuo, MC
    Huang, CF
    CANCER, 2004, 101 (05) : 989 - 998
  • [47] The prognosis predictive value of FMS-like tyrosine kinase 3-internal tandem duplications mutant allelic ratio (FLT3-ITD MR) in patients with acute myeloid leukemia detected by GeneScan
    Lyu, Mengyuan
    Liao, Hongyan
    Shuai, Xiao
    Jin, Yongmei
    Su, Jun
    Zheng, Qin
    GENE, 2020, 726
  • [48] THE PROGNOSIS PREDICTIVE VALUE OF FMS-LIKE TYROSINE KINASE 3-INTERNAL TANDEM DUPLICATIONS MUTANT ALLELIC RATIO (FLT3-ITD MR) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA DETECTED BY GENESCAN
    Zheng, Qin
    Lyu, Mengyuan
    Liao, Hongyan
    Shuai, Xiao
    Jin, Yongmei
    Su, Jun
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 : 201 - 201
  • [49] Quantum-First: Safety By Treatment Phase and By Age in Newly Diagnosed (nd) Patients (pts) with FMS-like Tyrosine Kinase 3-Internal Tandem Duplication ( FLT3-ITD) Positive Acute Myeloid Leukemia (AML)
    Erba, Harry P.
    Dombret, Herve
    Perl, Alexander
    Mitov, Tsvetomir
    Liu, Li
    Kamel, Yasser Mostafa
    Imadalou, Karima
    Choi, Youngsook
    Levis, Mark J.
    Schlenk, Richard F.
    BLOOD, 2023, 142
  • [50] Improved outcomes among newly diagnosed patients with FMS-like tyrosine kinase 3 internal tandem duplication mutated acute myeloid leukemia treated with contemporary therapy: Revisiting the European LeukemiaNet adverse risk classification
    Reville, Patrick K.
    Sasaki, Koji
    Kantarjian, Hagop M.
    Daver, Naval G.
    Yilmaz, Musa
    Dinardo, Courtney D.
    Short, Nicholas J.
    Borthakur, Gautam
    Pemmaraju, Naveen
    Mehta, Rohtesh S.
    Pierce, Sherry
    Konoplev, Sergej N.
    Khoury, Joseph D.
    Garcia-Manero, Guillermo
    Konopleva, Marina Y.
    Jabbour, Elias
    Ravandi, Farhad
    Kadia, Tapan M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (03) : 329 - 337
12345